Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HR 330 (2021-2022)

https://ontology.bommaritollc.com/id/01a0d568-23e4-7035-884b-c3b9d2f94302

adms:identifier	mi-legislature-measure 2021-2022/HR/330
dcterms:temporal	Michigan Legislature, 2021-2022 session
primary sponsor	Julie M. Rogers
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-HR-0330 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-HR-0330 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-HR-0330
schema:legislationIdentifier	HR 330
schema:legislationJurisdiction	Michigan
schema:legislationType	resolution
schema:name	A resolution to urge the United States Food and Drug Administration to facilitate FDA approved research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.en
schema:sponsor	Tyrone Carter Regina Weiss Helena Scott Joseph Tate Stephanie A Young Samantha Steckloff Ranjeev Puri Julie M. Rogers Brenda Carter Cynthia Neeley Mike Mueller Julie Brixie Carol Glanville Amos O'Neal John R. Roth Gregory Markkanen Kevin Coleman Felicia Brabec Christine Morse Jim Haadsma Robert Bezotte Andrew Beeler Rachel Hood Mary Cavanagh Cara Clemente Kevin Hertel Yousef Rabhi Sarah Anthony Tommy Brann Gary Eisen Terry J. Sabo Beau LaFave Sara Cambensy Jeffrey D. Pepper
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-HR-0330
skos:prefLabel	HR 330 (2021-2022)en